Retweeted Charles Ornstein (@charlesornstein): Pl…

Retweeted Charles Ornstein (@charlesornstein): Please don’t take medical advice from celebrities or the… fb.me/4lRdvC41j

@charlesornstein Mess indeed. The networks, premiu…

@charlesornstein Mess indeed. The networks, premium pricing of HIX plans in subsidy sweet spot often not structured to absorb CO-OP members

@charlesornstein Wonder how their practices affect…

@charlesornstein Wonder how their practices affected drug prices they reported (ASP for Medicare Part B, AMP and best price for Medicaid).

Retweeted Charles Ornstein (@charlesornstein): Te…

Retweeted Charles Ornstein (@charlesornstein): Tens of Thousands Who Didn’t File Tax Returns May Lose Health… fb.me/47VUekIMa

Retweeted Charles Ornstein (@charlesornstein): La…

Retweeted Charles Ornstein (@charlesornstein): Lawsuit provides critical new material to those concerned with… fb.me/39MsaP8VD

Retweeted Charles Ornstein (@charlesornstein): Du…

Retweeted Charles Ornstein (@charlesornstein): During first six months of 2015, Medicare spent $4.6 BILLION on… fb.me/4oXYviEK5

@charlesornstein @ScottGottliebMD Some therapeutic…

@charlesornstein @ScottGottliebMD Some therapeutic classes what Rx works is very idiosyncratic to patient, adherence not unit $ price key.

@ScottGottliebMD @charlesornstein Exactly, Scott….

@ScottGottliebMD @charlesornstein Exactly, Scott. And because Mcare has drug-only risk plans. Plus CMS oversight of formularies is poor.

@charlesornstein Reducing # of drugs on formulary…

@charlesornstein Reducing # of drugs on formulary steers vol, increases rebates, cuts Rx budget. Easier to do for some classes than others.

@charlesornstein In general, I agree but Part D is…

@charlesornstein In general, I agree but Part D is unique. Most D plans only at risk for drug costs so don’t consider other costs, value.